Original Research
Published on 21 May 2025
Successful treatment of hairy cell leukaemia with pegylated interferon-alpha-2A
Pathology and Oncology Research
doi 10.3389/pore.2025.1612108
2,973 Publications
volumes
Volume 31 - 2025
Review
Published on 12 May 2025
How to differentiate primary mucinous ovarian tumors from ovarian metastases originating from primary appendiceal mucinous neoplasms: a review
Pathology and Oncology Research
doi 10.3389/pore.2025.1612066
Original Research
Published on 01 May 2025
MRI-based image-guided adaptive brachytherapy for locally advanced cervical cancer in clinical routine: a single-institution experience
Pathology and Oncology Research
doi 10.3389/pore.2025.1612077
![HER2 expression in different cell lines at different inoculation sites assessed by [52Mn]Mn-DOTAGA(anhydride)-trastuzumab](https://www.por-journal.com/files/myhome article library/1611999/1611999_Thumb_400.jpg)
Original Research
Published on 29 Apr 2025
HER2 expression in different cell lines at different inoculation sites assessed by [52Mn]Mn-DOTAGA(anhydride)-trastuzumab
Pathology and Oncology Research
doi 10.3389/pore.2025.1611999
Original Research
Published on 28 Apr 2025
Association between Kaposi’s sarcoma-associated herpesvirus genotype and clinical types
Pathology and Oncology Research
doi 10.3389/pore.2025.1612009
Original Research
Published on 15 Apr 2025
Evaluation of dysplasias associated with inflammatory bowel disease—a single-center, retrospective, 5-year experience
Pathology and Oncology Research
doi 10.3389/pore.2025.1612105
Special Issue Editorial
Published on 11 Apr 2025
Editorial: New diagnostic and therapeutic possibilities in lung cancer
Pathology and Oncology Research
doi 10.3389/pore.2025.1612132
Case Report
Published on 08 Apr 2025
Timely recognition of a probably life-threatening genodermatosis: familial case report of hereditary leiomyomatosis and renal cell cancer
Pathology and Oncology Research
doi 10.3389/pore.2025.1612086
Original Research
Published on 04 Apr 2025
Photobleaching alters the morphometric analysis of fluorescently labeled neurons and microglial cells
Pathology and Oncology Research
doi 10.3389/pore.2025.1612087
Original Research
Published on 01 Apr 2025
Real-world experience with pazopanib in locally advanced and metastatic soft tissue sarcomas: a Hungarian retrospective single-center study
Pathology and Oncology Research
doi 10.3389/pore.2025.1611965
Original Research
Published on 21 Mar 2025
Neoadjuvant leukocyte interleukin injection immunotherapy improves overall survival in low-risk locally advanced head and neck squamous cell carcinoma –the IT-MATTERS study
Pathology and Oncology Research
doi 10.3389/pore.2025.1612084
Brief Research Report
Published on 14 Mar 2025
Are patients with chronic obstructive pulmonary disease at a greater risk for the development of autoimmune thyroiditis as an adverse event of immunotherapy in non-small cell lung cancer treatment?
Pathology and Oncology Research
doi 10.3389/pore.2025.1612022
Original Research
Published on 12 Mar 2025
Impact of comprehensive genomic profiling on the diagnosis and clinical management of malignant mesenchymal tumours
Pathology and Oncology Research
doi 10.3389/pore.2025.1612065
Original Research
Published on 11 Mar 2025
Characterization of a novel sarcoma cell line with an EWSR1::POU2AF3 fusion
Pathology and Oncology Research
doi 10.3389/pore.2025.1611986
Case Report
Published on 10 Mar 2025
Case Report: Importance of high-throughput genetic investigations in the differential diagnosis of unexplained erythrocytosis
Pathology and Oncology Research
doi 10.3389/pore.2025.1612037
Case Report
Published on 06 Mar 2025
Case report: Alectinib-associated intestinal ulceration and colitis in a patient with non-small cell lung cancer and effective treatment with Mesalazine
Pathology and Oncology Research
doi 10.3389/pore.2025.1612040
Original Research
Published on 04 Mar 2025
Survival trends of gastrointestinal stromal tumor in real-world settings: a population-based retrospective study
Pathology and Oncology Research
doi 10.3389/pore.2025.1611896
Original Research
Published on 19 Feb 2025
Management and surveillance of metastatic giant cell tumour of bone
Pathology and Oncology Research
doi 10.3389/pore.2025.1611916
Original Research
Published on 13 Feb 2025
A novel automated IHC staining system for quality control application in ALK immunohistochemistry testing
Pathology and Oncology Research
doi 10.3389/pore.2025.1611964
Original Research
Published on 12 Feb 2025
Tumour budding in invasive ductal breast carcinomas: correlation with clinicopathological prognostic parameters and hormone receptor status
Pathology and Oncology Research
doi 10.3389/pore.2025.1611983
Original Research
Published on 20 Jan 2025
CD34 evaluation of microvasculature in lung adenocarcinoma and its microvascular density predicts postoperative tumor recurrence
Pathology and Oncology Research
doi 10.3389/pore.2025.1611985
Volume 30 - 2024
Original Research
Published on 08 Jan 2025
Evaluating the correlation between pretreatment 18F-FDG PET/CT metabolic parameters and tumor-infiltrating lymphocyte levels in nonluminal breast cancer and impact on survival
Pathology and Oncology Research
doi 10.3389/pore.2024.1612014
Original Research
Published on 07 Jan 2025
NTRK amplification occurs frequently in pan-TRK immunopositive dedifferentiated liposarcomas
Pathology and Oncology Research
doi 10.3389/pore.2024.1611993
Original Research
Published on 06 Jan 2025
Anti-ceramide antibody and sphingosine-1-phosphate as potential biomarkers of unresectable non-small cell lung cancer
Pathology and Oncology Research
doi 10.3389/pore.2024.1611929